Blog

May 10, 2026

Oral semaglutide (Rybelsus) is FDA-approved for type 2 diabetes but not for chronic weight management. The injectable form (Wegovy, 2.4mg weekly) is the only FDA-approved semaglutide formulation for weight loss. Rybelsus produces approximately 4.4% body weight reduction vs. 14.9% with Wegovy in clinical data, primarily because oral bioavailability of semaglutide is approximately 1% compared to […]

May 4, 2026

Tirzepatide (Zepbound) produces greater average weight loss than semaglutide (Wegovy) in head-to-head trial data. The SURMOUNT-5 trial (2025) found tirzepatide reduced body weight by approximately 20.2% vs. 13.7% for semaglutide over 72 weeks. Both are FDA-approved injectable medications for chronic weight management, but they work through different receptor mechanisms, follow different dosing schedules, and carry […]

May 1, 2026

Depression and low testosterone are clinically connected in both directions. Testosterone acts on androgen receptors in limbic and prefrontal brain regions that regulate mood, motivation, and stress response. Deficiency in these pathways produces depressive symptoms that are often indistinguishable from primary major depressive disorder. At the same time, depression itself suppresses testosterone production through the […]

Apr 24, 2026

TRT withdrawal refers to the cluster of symptoms that occur after stopping testosterone replacement therapy, caused by suppression of the body’s natural testosterone production during treatment. Common symptoms include fatigue, low mood, reduced libido, and muscle loss — and they persist until the hypothalamic–pituitary–gonadal (HPG) axis recovers and endogenous testosterone production resumes. Recovery typically takes […]

Apr 19, 2026

TRT withdrawal refers to the cluster of symptoms that occur after stopping testosterone replacement therapy, caused by suppression of the body’s natural testosterone production during treatment. Common symptoms include fatigue, low mood, reduced libido, and muscle loss — and they persist until the hypothalamic–pituitary–gonadal (HPG) axis recovers and endogenous testosterone production resumes. Recovery typically takes […]

Apr 16, 2026

Semaglutide and alcohol — the combination is more complex than most patients are told. It’s not a straightforward contraindication — semaglutide doesn’t cause a dangerous reaction with alcohol the way some medications do. But the interaction affects tolerability, blood sugar stability, cardiovascular risk, and in some patients, the desire to drink at all. This guide […]

Apr 11, 2026

Stopping testosterone replacement therapy without a plan is not a clinical strategy, it’s a risk. Whether you’re pausing treatment to conceive, reassessing long-term therapy, or managing side effects, coming off TRT requires a structured tapering protocol and physician oversight. This guide covers the clinical steps, what your body goes through, and how to protect your […]

Apr 5, 2026

The dosage for tirzepatide follows a fixed FDA-approved escalation schedule: starting at 2.5mg weekly and increasing every four weeks up to a maximum of 15mg. This complete dosage guide covers what each dose achieves clinically, when to slow or pause escalation, how dosing differs between weight management and type 2 diabetes, and what drug interactions […]

Mar 30, 2026

Your first tirzepatide injection is 2.5mg. Not because it will cause dramatic weight loss — it won’t — but because it prepares your body for the doses that will. This mandatory 4-week phase lets your GI system adapt before escalation begins. Most patients find it harder than they expected. This guide tells you exactly what […]

Mar 24, 2026

Short answer: To get semaglutide for weight loss, you need a prescription from a licensed clinician. You typically qualify with a BMI of 30 or higher, or 27 or higher with a weight-related condition. The process involves a medical evaluation, lab work, and an ongoing monitoring plan. This guide covers every step — from eligibility […]

Mar 18, 2026

Short answer: Tirzepatide most commonly causes nausea (~44%), diarrhea (~30%), vomiting (~25%), and constipation (~22%). These GI effects usually peak in weeks 2–4 and often improve by weeks 8–12 as the body adapts. Serious events such as pancreatitis and gallbladder disease are uncommon but require prompt medical attention. What is tirzepatide? Tirzepatide is a dual […]

Mar 14, 2026

If you’re on testosterone replacement therapy (TRT) and enjoy an occasional drink, you’ve probably asked yourself: can you drink alcohol on TRT? The short answer is yes — light to moderate drinking on TRT is generally tolerated by most patients. But the details matter, and they matter more than you might expect. Alcohol and testosterone […]